SLDB - Solid Biosciences LLC logo

Solid Biosciences LLC

SLDB

Solid Biosciences develops gene therapies for neuromuscular and cardiac diseases, with candidates such as SGT-003 for Duchenne muscular dystrophy. It also works on technologies for gene delivery and collaborates with various academic institutions.

⚕️ Healthcare NASDAQ Listed 2018 $ USD
$1,000 invested 5 years ago →$203today

Score Overview

1 Year
Score—
Net Growth-18.80%
Net TrendShrank
Net Income Consistency—
Rev Growth—
Rev TrendShrank
Revenue Consistency—
5 Years
Score0.4
Net Growth-186.89%
Net TrendNever
Net Income Consistency—
Rev Growth-100.00%
Rev TrendNever
Revenue Consistency—
All Time
Score—
Net Growth-176.88%
Net Trend25%
Net Income Consistency
Rev Growth—
Rev Trend25%
Revenue Consistency

Explore the 2021 public Archive ranking →

Where Solid Biosciences LLC has ranked, year by year

Measure
Fundamentals Window

Not enough ranking history to display a chart

This chart needs at least two years of available HDB Score rankings on 10 years of fundamentals. SLDB does not have enough ranked years in the public Archive through 2021.

More recent Archive years are available with Membership. Coverage varies by company and measure.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-10-22
$ 6.19—
1 Year2025-10-22
$ 5.649.75%
5 Years2021-10-22
$ 30.45-79.67%
All Time2018-01-26
$ 339.30-98.18%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Reported in USD

Year
TTM$ 0.00-$ 207M$ 377M
2025$ 0.00-$ 174M$ 187M
2024$ 0.00-$ 124M$ 148M
2023$ 0.00-$ 96M$ 123M
2022$ 8M-$ 85M$ 213M
2021$ 13M-$ 72M$ 207M
2020$ 3M-$ 88M$ 154M
2019$ 0.00-$ 117M$ 83M
IPO2018$ 0.00-$ 74M$ 122M
SLDB - Solid Biosciences LLC logo

Solid Biosciences LLC fundamental performance

Between 2020 and 2025, revenue declined from $ 3M to $ 0.00 and net income went from -$ 88M to -$ 174M. Revenue increased in 0 of those 5 years; net income in 0.

Solid Biosciences LLC currently holds a 5-year HDB Score of 0.4 out of 10. How the HDB Score is calculated.

Membership

Explore SLDB with current data

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 5,119 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$99 / year

$149/year · Founding price

Continue with Membership

30-day money-back guarantee.

Explore other companies